0001415889-24-006310.txt : 20240304
0001415889-24-006310.hdr.sgml : 20240304
20240304172409
ACCESSION NUMBER: 0001415889-24-006310
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Markel Stacy
CENTRAL INDEX KEY: 0001734780
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 24716020
MAIL ADDRESS:
STREET 1: RIGEL PHARMACEUTICALS, INC.
STREET 2: 1180 VETERANS BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4
1
form4-03042024_100304.xml
X0508
4
2024-02-29
0001811063
Nuvation Bio Inc.
NUVB
0001734780
Markel Stacy
C/O NUVATION BIO INC.
1500 BROADWAY, SUITE 1401
NEW YORK
NY
10036
false
true
false
false
CHIEF PEOPLE OFFICER
0
Class A Common Stock
10591
D
Stock Option (Right to Buy)
1.87
2024-02-29
4
A
0
500000
0
A
2034-02-27
Class A Common Stock
500000
500000
D
Includes 3,000 shares acquired on May 19, 2023 and 3,000 shares acquired on November 17, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.
Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
/s/ Ron A. Metzger, Attorney-in-Fact
2024-03-04